血清CA - 125在子宫肉瘤患者监测中的应用。初步报告。
Use of serum CA-125 in monitoring patients with uterine sarcoma. A preliminary report.
作者信息
Patsner B, Mann W J
机构信息
Department OB/GYN, SUNY at Stony Brook, School of Medicine 11794-8091.
出版信息
Cancer. 1988 Oct 1;62(7):1355-8. doi: 10.1002/1097-0142(19881001)62:7<1355::aid-cncr2820620719>3.0.co;2-4.
Abstract
Elevated preoperative serum CA-125 levels were present in three of four patients (75%) with Stage I uterine sarcoma found to have extrauterine spread of disease at laparotomy as well as five of seven (71%) patients with clinically advanced and recurrent uterine sarcoma. Serial levels during chemotherapy inconsistently reflected response to treatment and proved to have limited clinical value.
摘要
在接受剖腹手术时发现有子宫外疾病扩散的4例I期子宫肉瘤患者中，有3例（75%）术前血清CA - 125水平升高；在7例临床晚期和复发性子宫肉瘤患者中，有5例（71%）也是如此。化疗期间的系列CA - 125水平并不能始终如一地反映对治疗的反应，且临床价值有限。
Zotero 插件